Document Detail


Timing of Arteriovenous Fistula Creation in Patients With CKD: A Decision Analysis.
MedLine Citation:
PMID:  23978336     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The optimal time for arteriovenous fistula (AVF) referral is uncertain. Improving the timeliness of referral may reduce central venous catheter (CVC) use.
STUDY DESIGN: Monte Carlo simulation model.
SETTING & POPULATION: Patients with chronic kidney disease (CKD) followed up in a multidisciplinary clinic, overall and stratified by age.
MODEL, PERSPECTIVE, & TIMEFRAME: Decision analysis, patient, patient's lifetime.
INTERVENTION: AVF referral, using 1 of 2 strategies: refer when hemodialysis is anticipated to begin within a certain time frame or refer when estimated glomerular filtration rate (eGFR) drops below a certain threshold.
OUTCOMES: A range of values for each strategy are compared to each other with respect to incident vascular access type (AVF or CVC), percentage of patients with an unnecessary AVF creation, and life expectancy after dialysis therapy initiation.
RESULTS: A 15-month referral time frame gave 34% with incident CVCs, 14% with unnecessary AVFs, and a life expectancy of 1,751 days. Time frames of 12-18 months performed similarly. Referral at eGFR of 20mL/min/1.73m(2) gave 38% with incident CVCs, 20% with unnecessary AVFs, and life expectancy of 1,742 days. Using an eGFR threshold of 15mL/min/1.73m(2), 10% had an unnecessary AVF. Policy performance was affected by CKD progression rate and age. For fast progressors (ΔeGFR = -7mL/min/1.73m(2) per year), referral at eGFR of 25mL/min/1.73m(2) achieved a similar incident CVC percentage (∼40%) as referral at 15mL/min/1.73m(2) in slower progressors (ΔeGFR = -2.78mL/min/1.73m(2) per year). For patients aged 70-80 and 80-90 years, time frames of 15-18 months yielded 16%-22% with unnecessary AVFs (vs 9%-11% in 50- to 60-year-olds); an eGFR threshold strategy of 20mL/min/1.73m(2) yielded 24% unnecessary AVFs in 80- to 90-year-olds versus 16% in 50- to 60-year-olds.
LIMITATIONS: Our model does not consider patients with nonlinear CKD progression or acute kidney injury. We did not include arteriovenous grafts or consider cost or quality of life.
CONCLUSIONS: In general, AVF referral within about 12 months of the estimated time to dialysis performed best among time frame strategies, and referral at eGFR < 15-20mL/min/1.73 m(2) performed best among threshold strategies. The timing of referral should also be guided by the individual rate of CKD progression. Elderly patients with CKD could be referred later to reduce the risk of creating an AVF that is never used.
Authors:
Steven M Shechter; M Reza Skandari; Nadia Zalunardo
Related Documents :
10228256 - Features that may predict hospital admission following outpatient therapeutic ercp.
18503696 - Therapeutic plasma exchange for acute hyperlipidemic pancreatitis: a case series.
19220676 - Effect of antibiotic prophylaxis on acute necrotizing pancreatitis: results of a random...
23580116 - Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for th...
16199246 - An open-label, noncomparative study of miglustat in type i gaucher disease: efficacy an...
22440366 - Do pericardial bioprostheses improve outcome of elderly patients undergoing aortic valv...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-8-23
Journal Detail:
Title:  American journal of kidney diseases : the official journal of the National Kidney Foundation     Volume:  -     ISSN:  1523-6838     ISO Abbreviation:  Am. J. Kidney Dis.     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-8-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8110075     Medline TA:  Am J Kidney Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Affiliation:
Sauder School of Business, Department of Medicine, University of British Columbia, Vancouver, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  FGF-1 Delivery from Multilayer Alginate Microbeads Stimulates a Rapid and Persistent Increase in Vas...
Next Document:  Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus t...